Premenstrual Dysphoric Disorder and Affective Temperament in Patients with Polycystic Ovary Syndrome

TAS, HALIL IBRAHIM; BEYAZIT, Fatma; ERTEKİN, Hülya; ERTEKİN, Yusuf Haydar; ŞAHİN, Başak; Asik, Mehmet Burak

Premenstrual Dysphoric Disorder and Affective Temperament in Patients with Polycystic Ovary Syndrome

Hülya ERTEKİN, (Çanakkale Onsekiz Mart Üniversitesi)

Başak ŞAHİN, (Çanakkale Onsekiz Mart Üniversitesi)

Halil İbrahim TAŞ, (Çanakkale Onsekiz Mart Üniversitesi)

Fatma BEYAZIT, (Çanakkale Onsekiz Mart Üniversitesi)

Mehmet AŞIK, (Özel Tekden Hastanesi)

Yusuf Haydar ERTEKİN (Çanakkale Onsekiz Mart Üniversitesi)

Kocaeli Tıp Dergisi

5 2

Yıl: 2018 Cilt: 7 Sayı: 3 Sayfa Aralığı: 118 - 123 Metin Dili: İngilizce İndeks Tarihi: 08-03-2020

Premenstrual Dysphoric Disorder and Affective Temperament in Patients with Polycystic Ovary Syndrome

Öz:

INTRODUCTION: This study aimed to evaluate the affectivetemperaments of women with Polycystic Ovary Syndrome(PCOS), to assess its comorbidity with PremenstrualDysphoric Disorder (PMDD) and compare with HealthyControls (HC).METHODS: A total of 20 women with PCOS and 20 HC wereincluded in this study. Hospital Anxiety and Depression Scale(HADS) and Temperament Evaluation of Memphis, Pisa, Parisand San Diego-Autoquestionnaire version (TEMPS-A) wereapplied to all participants. The Diagnoses of PMDD and otherpsychiatric disorders were made by staff psychiatristsinterviewing all participants using DSM-5 diagnostic criteria.RESULTS: The comorbidity of PMDS in patients with PCOSwas 30% (n=6), while it was 15% (n=3) in the HC group.PMDS proportions did not differ significantly between groups.Patients with PCOS had higher major depression (25%, n=5)and anxiety disorders (20%, n=4) compared with HCs, butonly anxiety disorders were significantly higher in PCOS thanthe HC group (p=0.03).DISCUSSION and CONCLUSION: Patients with PCOS mayhave more comorbidity risk of PMDD, which is a mooddisorder according to DSM–5, and associated with menstrualcycles. Considering and treating PMDD and other psychiatricconditions may increase the quality of life and functionality ofwomen with PCOS.

Anahtar Kelime:

Polikistik Over Sendromlu Hastalarda Premenstrüel Disforik Bozukluk ve Affektif Mizaç

Öz:

GİRİŞ ve AMAÇ: Bu çalışmada, Polikistik Over Sendromu (PKOS) olan kadınların, afektif mizaç özelliklerini ve Premenstrual Disforik Bozukluk (PMDB) komorbiditesini değerlendirmek ve Sağlıklı Kontrollerle (SK) karşılaştırmayı hedefledik. YÖNTEM ve GEREÇLER: Bu çalışmaya 20 PKOS hastası ve 20 SK dahil edildi. Tüm katılımcılara Hastane Anksiyete ve Depresyon Ölçeği (HADÖ) ve Mizaç Karakter Envanteri (Temperament Evaluation of Memphis, Pisa, Paris and San Diego-Autoquestionnaire version (TEMPS-A)) uygulandı. PMDB ve diğer psikiyatrik bozuklukların tanıları, DSM-5 tanı ölçütlerini kullanarak tüm katılımcılarla bire bir görüşen uzman psikiyatristler tarafından yapıldı. BULGULAR: PKOS'lu hastalarda PMDB'nin eştanısı% 30 (n = 6) iken SK grubunda % 15 (n = 3) idi. PMDB oranları bakımından gruplar arasında anlamlı farklılık gözlenmedi. PKOS'lu hastalarda SK'lere göre daha yüksek oranda majör depresyon (% 25, n = 5) ve anksiyete bozukluğu (% 20, n = 4) olmakla birlikte, sadece anksiyete bozuklukları PKOS'da SK grubuna göre anlamlı derecede yüksekti (p = 0.03). TARTIŞMA ve SONUÇ: PKOS'lu hastalar, DSM-5’e göre duygudurum bozuklukları arasında olan ve adet döngüsü ile ilişkili olan PMDB komorbiditesi açısından risk faktörüne sahip olabilirler. PKOS’lu kadınlarda, PMDB ve diğer psikiyatrik durumları düşünmek ve tedavi etmek, bu hastaların yaşam kalitesini ve işlevselliğini artırabilir.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005;11:1223–36.
2. Li Y, Li Y, Yu Ng EH, Stener-Victorin E, Hou L, Wu T, et al. Polycystic ovary syndrome is associated with negatively variable impacts on domains of health-related quality of life: evidence from a meta-analysis. Fertil Steril 2011;96: 452–8.
3. Hahn S, Janssen OE, Tan S, Pleger K, Mann K, Schedlowski M, et al. Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome. Eur J Endocrinol 2005;11:853–60.
4. Setji, TL, Brown AJ. Polycystic ovary syndrome: update on diagnosis and treatment. Am J Med 2014;127:912–9.
5. Davari-Tanha F, Hosseini Rashidi B, Ghajarzadeh M, Noorbala AA. Bipolar disorder in women with polycystic ovarian syndrome (PCOS). Acta Med Iran 2014;52(1):46–8.
6. Kerchner A, Lester W, Stuart SP, Dokras A. Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study. Fertil Steril 2009;91(1):207–12.
7. Bhattacharya SM, Jha A. Prevalence and risk of depressive disorder in women with polycystic ovary syndrome (PCOS). Fertil Steril 2010;94:357– 9.
8. Jedel E, Waern M, Gustafson D, Landén M, Eriksson E, Holm G, et al. Anxiety and depression symptoms in women with polycystic ovary syndrome compared with controls matched for body mass index. Hum Reprod 2010;25(2):450-6.
9. Naqvi SH, Moore A, Bevilacqua K, Lathief S, Williams J, Naqvi N, et al. Predictors of depression in women with polycystic ovary syndrome. Arch Womens Ment Health 2015;18:95– 101.
10. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA: American Psychiatric Association; 2013.
11. Nevatte T, O 'Brien PM, Backstrom T, Brown C, Dennerstein L, Endicott J, et al. Is PMD consensus on the management of premenstrual disorders. Arch Women Ment Health 2013;1 6:279 -91.
12. Yonkers KA, O'Brien PM, Eriksson E. Premenstrual syndrome. Lancet 2008;371: 1200 - 1210.
13. Akiskal HS, Akiskal KK, Haykal RF, Manning JS, Connor PD. TEMPS-A: progress towards validation of a self-rated clinical version of the Temperament Evaluation of the Memphis, Pisa, Paris, and San Diego Autoquestionnaire. J Affect Disord 2005; 85;3 – 16.
14. de Aguiar Ferreira A, Vasconcelos AG, Neves FS, Correa H. Affective temperaments and antidepressant response in the clinical management of mood disorders J Affect Disord 2014; 155:138– 41.
15. Kesebir A, Gundogar D, Kucuksubas Y, Tatlıdil Yaylacı E. The relation between affective temperament and resilience in depression: A controlled study. J Affect Disord 2013; 148:352–6.
16. Park C, An SK, Kim HW, Koh MJ, Namkoong K, Kang JI. Relationships between chronotypes and affective temperaments in healthy young adults. J Affect Disord 2015;175:256–9.
17. Shahini M, Shala M, Xhylani P, Gashi S, Borinca I, Erfurth A. Challenging predictions between affective temperaments, depression and anxiety in a Kosovo student community sample. Int J Psychiatry Clin Pract 2018:26:1-7.
18. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41–7.
19. Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, Murad MH, Pasquali R. Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2013;98:4565–92.
20. Ferriman D, Gallwey JD Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961;21:1440–7.
21. Kerchner A, Lester W, Stuart SP, Dokras A. Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study. Fertil Steril 2009;91:207–12.
22. Tan J, Wang QY, Feng GM, Li XY, Huang W. Increased Risk of Psychiatric Disorders in Women with Polycystic Ovary Syndrome in Southwest China. Chin Med J. 2017; 5;130(3):262- 6.
23. Annagür BB, Kerimoglu ÖS, Tazegül A, Gündüz Ş, Gençoglu BB. Psychiatric comorbidity in women with polycystic ovary syndrome. J Obstet Gynaecol Res 2015; 41(8):1229-33.
24. Asik M, Altinbas K, Eroglu M, Karaahmet E, Erbag G, Ertekin HEvaluation of affective temperament and anxiety-depression levels of patients with polycystic ovary syndrome. J Affect Disord 2015 1;185:214-8
25. Khazaie H, Ghadami MR, Khaledi-Paveh B, Chehri A, Nasouri M. Sleep Quality in University Students with Premenstrual Dysphoric Disorder. Shanghai Arch Psychiatry 2016; 28(3):131-3.
26. Rubinow DR, Schmidt PJ. Gonadal steroid regulation of mood: The lessons of premenstrual syndrome. Front Neuroendocrinol 2006; 27 (2):210–6.
27. Freeman EW, Halbreich U, Grubb GS. An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndrome. Contraception 2012;85(5):437-45.
28. Sveindottir H, Backstrom T. Prevalence of menstrual cycle symptom cyclicity and premenstrual dysphoric disorder in a random sample of women using and not using oral contraceptives. Acta Obstet Gynecol Scand 2000;79(5):405-13.
29. Hollinrake E, Abreu A, Maifeld M, Van Voorhis BJ, Dokras A. Increased risk of depressive disorders in women with polycystic ovary syndrome. Fertil Steril 2007;87(6):1369-76.
30. Blay SL, Aguiar JV, Passos IC. Polycystic ovary syndrome and mental disorders: a systematic review and exploratory meta-analysis. Neuropsychiatr Dis Treat 2016;12:2895-903.

APA	ERTEKİN H, ŞAHİN B, TAS H, BEYAZIT F, Asik M, ERTEKİN Y (2018). Premenstrual Dysphoric Disorder and Affective Temperament in Patients with Polycystic Ovary Syndrome. , 118 - 123.
Chicago	ERTEKİN Hülya,ŞAHİN Başak,TAS HALIL IBRAHIM,BEYAZIT Fatma,Asik Mehmet Burak,ERTEKİN Yusuf Haydar Premenstrual Dysphoric Disorder and Affective Temperament in Patients with Polycystic Ovary Syndrome. (2018): 118 - 123.
MLA	ERTEKİN Hülya,ŞAHİN Başak,TAS HALIL IBRAHIM,BEYAZIT Fatma,Asik Mehmet Burak,ERTEKİN Yusuf Haydar Premenstrual Dysphoric Disorder and Affective Temperament in Patients with Polycystic Ovary Syndrome. , 2018, ss.118 - 123.
AMA	ERTEKİN H,ŞAHİN B,TAS H,BEYAZIT F,Asik M,ERTEKİN Y Premenstrual Dysphoric Disorder and Affective Temperament in Patients with Polycystic Ovary Syndrome. . 2018; 118 - 123.
Vancouver	ERTEKİN H,ŞAHİN B,TAS H,BEYAZIT F,Asik M,ERTEKİN Y Premenstrual Dysphoric Disorder and Affective Temperament in Patients with Polycystic Ovary Syndrome. . 2018; 118 - 123.
IEEE	ERTEKİN H,ŞAHİN B,TAS H,BEYAZIT F,Asik M,ERTEKİN Y "Premenstrual Dysphoric Disorder and Affective Temperament in Patients with Polycystic Ovary Syndrome." , ss.118 - 123, 2018.
ISNAD	ERTEKİN, Hülya vd. "Premenstrual Dysphoric Disorder and Affective Temperament in Patients with Polycystic Ovary Syndrome". (2018), 118-123.

APA	ERTEKİN H, ŞAHİN B, TAS H, BEYAZIT F, Asik M, ERTEKİN Y (2018). Premenstrual Dysphoric Disorder and Affective Temperament in Patients with Polycystic Ovary Syndrome. Kocaeli Tıp Dergisi, 7(3), 118 - 123.
Chicago	ERTEKİN Hülya,ŞAHİN Başak,TAS HALIL IBRAHIM,BEYAZIT Fatma,Asik Mehmet Burak,ERTEKİN Yusuf Haydar Premenstrual Dysphoric Disorder and Affective Temperament in Patients with Polycystic Ovary Syndrome. Kocaeli Tıp Dergisi 7, no.3 (2018): 118 - 123.
MLA	ERTEKİN Hülya,ŞAHİN Başak,TAS HALIL IBRAHIM,BEYAZIT Fatma,Asik Mehmet Burak,ERTEKİN Yusuf Haydar Premenstrual Dysphoric Disorder and Affective Temperament in Patients with Polycystic Ovary Syndrome. Kocaeli Tıp Dergisi, vol.7, no.3, 2018, ss.118 - 123.
AMA	ERTEKİN H,ŞAHİN B,TAS H,BEYAZIT F,Asik M,ERTEKİN Y Premenstrual Dysphoric Disorder and Affective Temperament in Patients with Polycystic Ovary Syndrome. Kocaeli Tıp Dergisi. 2018; 7(3): 118 - 123.
Vancouver	ERTEKİN H,ŞAHİN B,TAS H,BEYAZIT F,Asik M,ERTEKİN Y Premenstrual Dysphoric Disorder and Affective Temperament in Patients with Polycystic Ovary Syndrome. Kocaeli Tıp Dergisi. 2018; 7(3): 118 - 123.
IEEE	ERTEKİN H,ŞAHİN B,TAS H,BEYAZIT F,Asik M,ERTEKİN Y "Premenstrual Dysphoric Disorder and Affective Temperament in Patients with Polycystic Ovary Syndrome." Kocaeli Tıp Dergisi, 7, ss.118 - 123, 2018.
ISNAD	ERTEKİN, Hülya vd. "Premenstrual Dysphoric Disorder and Affective Temperament in Patients with Polycystic Ovary Syndrome". Kocaeli Tıp Dergisi 7/3 (2018), 118-123.